AC Immune (ACIU) Equity Ratio (2016 - 2025)
AC Immune (ACIU) has disclosed Equity Ratio for 9 consecutive years, with 0.49 as the latest value for Q4 2024.
- On a quarterly basis, Equity Ratio fell 44.67% to 0.49 in Q4 2024 year-over-year; TTM through Dec 2024 was 0.49, a 44.67% decrease, with the full-year FY2024 number at 0.49, down 44.67% from a year prior.
- Equity Ratio was 0.49 for Q4 2024 at AC Immune, down from 0.88 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.91 in Q4 2022 to a low of 0.49 in Q4 2024.
- A 5-year average of 0.81 and a median of 0.89 in 2021 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: rose 2.43% in 2022, then plummeted 44.67% in 2024.
- AC Immune's Equity Ratio stood at 0.9 in 2020, then decreased by 1.69% to 0.89 in 2021, then increased by 2.43% to 0.91 in 2022, then dropped by 3.32% to 0.88 in 2023, then tumbled by 44.67% to 0.49 in 2024.
- Per Business Quant, the three most recent readings for ACIU's Equity Ratio are 0.49 (Q4 2024), 0.88 (Q4 2023), and 0.91 (Q4 2022).